# TGF-β Isoforms and Local Environments Greatly Modulate Biological Nature of Human Retinal Pigment Epithelium Cells

**Authors:** Nami Nishikiori, Tatsuya Sato, Toshifumi Ogawa, Megumi Higashide, Araya Umetsu, Soma Suzuki, Masato Furuhashi, Hiroshi Ohguro, Megumi Watanabe

PMC · DOI: 10.3390/bioengineering11060581 · 2024-06-07

## TL;DR

This study shows how different TGF-β forms and oxygen levels affect human retinal cells in 2D and 3D models, influencing their function and structure.

## Contribution

The study reveals distinct biological effects of TGF-β isoforms on RPE cells under normoxia and hypoxia in 2D and 3D models.

## Key findings

- TGF-β1 and TGF-β3 significantly increased trans-epithelial electrical resistance (TEER) values in RPE cells.
- TGF-β isoforms reduced 3D spheroid size, with TGF-β1 being the most effective under both normoxia and hypoxia.
- TGF-β isoforms altered mitochondrial and glycolytic functions differently depending on oxygen levels and culture conditions.

## Abstract

To characterize transforming growth factor-β (TGF-β) isoform (TGF-β1~3)-b’s biological effects on the human retinal pigment epithelium (RPE) under normoxia and hypoxia conditions, ARPE19 cells cultured by 2D (two-dimensional) and 3D (three-dimensional) conditions were subjected to various analyses, including (1) an analysis of barrier function by trans-epithelial electrical resistance (TEER) measurements; (2) qPCR analysis of major ECM molecules including collagen 1 (COL1), COL4, and COL6; α-smooth muscle actin (αSMA); hypoxia-inducible factor 1α (HIF1α); and peroxisome proliferator-activated receptor-gamma coactivator (PGC1α), a master regulator for mitochondrial respiration;, tight junction-related molecules, Zonula occludens-1 (ZO1) and E-cadherin; and vascular endothelial growth factor (VEGF); (3) physical property measurements of 3D spheroids; and (4) cellular metabolic analysis. Diverse effects among TGF-β isoforms were observed, and those effects were also different between normoxia and hypoxia conditions: (1) TGF-β1 and TGF-β3 caused a marked increase in TEER values, and TGF-β2 caused a substantial increase in TEER values under normoxia conditions and hypoxia conditions, respectively; (2) the results of qPCR analysis supported data obtained by TEER; (3) 3D spheroid sizes were decreased by TGF-β isoforms, among which TGF-β1 had the most potent effect under both oxygen conditions; (4) 3D spheroid stiffness was increased by TGF-β2 and TGF-β3 or by TGF-β1 and TGF-β3 under normoxia conditions and hypoxia conditions, respectively; and (5) the TGF-β isoform altered mitochondrial and glycolytic functions differently under oxygen conditions and/or culture conditions. These collective findings indicate that the TGF-β-induced biological effects of 2D and 3D cultures of ARPE19 cells were substantially diverse depending on the three TGF-β isoforms and oxygen levels, suggesting that pathological conditions including epithelial–mesenchymal transition (EMT) of the RPE may be exclusively modulated by both factors.

## Linked entities

- **Genes:** COL1 (CONSTANS-like 1) [NCBI Gene 831442], COL4 (zinc finger CONSTANS-like protein) [NCBI Gene 832563], LOC100214647 (uncharacterized LOC100214647) [NCBI Gene 100214647], ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], TJP1 (tight junction protein 1) [NCBI Gene 7082], shg (shotgun) [NCBI Gene 37386], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422]
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TGFB3 (transforming growth factor beta 3) [NCBI Gene 7043] {aka ARVD, ARVD1, LDS5, RNHF, TGF-beta3}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, TGFB2 (transforming growth factor beta 2) [NCBI Gene 7042] {aka CAEND2, G-TSF, LDS4, TGF-beta2}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}
- **Diseases:** hypoxia (MESH:D000860)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** ARPE19 — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0145), RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11201039/full.md

---
Source: https://tomesphere.com/paper/PMC11201039